Genetics and genomics of radiotherapy toxicity: towards prediction
Genome Medicine2011Vol. 3(8), pp. 52–52
Citations Over TimeTop 10% of 2011 papers
Abstract
Radiotherapy is involved in many curative treatments of cancer; millions of survivors live with the consequences of treatment, and toxicity in a minority limits the radiation doses that can be safely prescribed to the majority. Radiogenomics is the whole genome application of radiogenetics, which studies the influence of genetic variation on radiation response. Work in the area focuses on uncovering the underlying genetic causes of individual variation in sensitivity to radiation, which is important for effective, safe treatment. In this review, we highlight recent advances in radiotherapy and discuss results from four genome-wide studies of radiotoxicity.
Related Papers
- → Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment(2018)287 cited
- → Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine(2022)118 cited
- → Radiogenomics for Precision Medicine With a Big Data Analytics Perspective(2018)66 cited
- → Precision Medicine in Radiomics and Radiogenomics(2022)9 cited
- → [Medical imaging in tumor precision medicine: opportunities and challenges].(2017)2 cited